Published in Int J Cancer on January 18, 1999
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest (2008) 2.24
Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am J Pathol (2001) 1.69
Integration of cell attachment, cytoskeletal localization, and signaling by integrin-linked kinase (ILK), CH-ILKBP, and the tumor suppressor PTEN. Mol Biol Cell (2003) 1.38
{beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer. Am J Pathol (2009) 1.37
Microenvironment and pathogenesis of epithelial ovarian cancer. Horm Cancer (2010) 1.30
Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis (2005) 1.30
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer. Neoplasia (2008) 1.29
Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. Br J Cancer (2005) 1.13
Targeted ovarian cancer treatment: the TRAILs of resistance. Am J Cancer Res (2011) 1.02
Current treatment options for colon cancer peritoneal carcinomatosis. World J Gastroenterol (2014) 1.00
Expression of alpha V-associated integrin beta subunits in epithelial ovarian cancer and its relation to prognosis in patients treated with platinum-based regimens. J Mol Histol (2005) 0.99
Integrin beta3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones. J Cancer Res Clin Oncol (2008) 0.94
Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on αv integrins. Clin Exp Metastasis (2014) 0.84
Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model. Am J Pathol (2004) 0.84
Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer. Ann Oncol (2014) 2.29
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol (2004) 1.81
Risk factors for brain relapse in patients with metastatic breast cancer. Ann Oncol (2004) 1.79
A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer. Lung Cancer (2003) 1.63
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann Oncol (2014) 1.45
Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study Group. Eur Heart J (1997) 1.45
Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials. Ann Oncol (2007) 1.29
Inhibition of mouse L cell protein synthesis by ultraviolet-irradiated vesicular stomatitis virus requires viral transcription. Virology (1978) 1.27
Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells. J Biol Chem (1998) 1.27
Cdx1 promotes differentiation in a rat intestinal epithelial cell line. Gastroenterology (1999) 1.25
Integrin ligation and PKC activation are required for migration of colon carcinoma cells. J Cell Sci (1998) 1.20
Evidence for anaphylactic reactions in peptic ulcer and varioliform gastritis. Ann Allergy (1983) 1.16
Expression and localization of alpha v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma. Gynecol Oncol (1996) 1.15
Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29. J Cell Sci (1986) 1.12
Assessment of DNA damage induced in vitro by etoposide and two fungicides (carbendazim and chlorothalonil) in human lymphocytes with the comet assay. Mutat Res (1997) 1.11
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors. Br J Cancer (2001) 1.10
The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Lett (2000) 1.09
mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions. Ann Oncol (2012) 1.06
Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals. Leukemia (2006) 1.03
Deficient processing and activity of type I insulin-like growth factor receptor in the furin-deficient LoVo-C5 cells. Endocrinology (1998) 1.03
Pulsefluorimetry of tyrosyl peptides. Biophys Chem (1978) 1.02
Lack of integrin alpha-chain endoproteolytic cleavage in furin-deficient human colon adenocarcinoma cells LoVo. Biochem J (1996) 1.01
A study of the immunological response to tumor ablation with irreversible electroporation. Technol Cancer Res Treat (2007) 1.01
Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4. J Biol Chem (1989) 1.01
Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature. Chest (1992) 1.00
Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells. Int J Cancer (1999) 0.99
Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells. Gynecol Oncol (2007) 0.99
Simultaneous production of IGF-I and EGF competing growth factors by HT-29 human colon cancer line. Int J Cancer (1987) 0.98
On the control of ribosomal protein biosynthesis in E. coli. IV. Studies on a temperature-sensitive mutant defective in the assembly of 50S subunits. Mol Gen Genet (1979) 0.97
TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression. Oncogene (2011) 0.96
Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers. Ann Oncol (2007) 0.95
Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer. Eur J Cancer (2012) 0.95
The RGD motif and the C-terminal segment of proprotein convertase 1 are critical for its cellular trafficking but not for its intracellular binding to integrin alpha5beta1. J Biol Chem (1999) 0.94
Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids. J Biol Chem (2001) 0.94
The in vivo order of protein addition in the course of Escherichia coli 30 S and 50 S subunit biogenesis. J Mol Biol (1975) 0.94
Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment. Gynecol Oncol (2006) 0.93
A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6. Cancer Res (1994) 0.92
Intraperitoneal linear polyethylenimine (L-PEI)-mediated gene delivery to ovarian carcinoma nodes in mice. Cancer Gene Ther (2006) 0.92
Cloning of mouse integrin alphaV cDNA and role of the alphaV-related matrix receptors in metanephric development. J Cell Biol (1996) 0.92
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer. Ann Oncol (2007) 0.91
Prevalence of alpha1-antitrypsin deficiency in patients with gastric or duodenal ulcer. Biomedicine (1974) 0.91
Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism. Cell Death Differ (2002) 0.91
t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia (2009) 0.91
Measurement of glycoprotein content and cell kinetics in preulcerous gastric mucosa. Dig Dis Sci (1979) 0.90
The role of intracellular lumina in the repolarization process of a colonic adenocarcinoma cell line. Virchows Arch B Cell Pathol Incl Mol Pathol (1984) 0.89
Protein kinases C-gamma and -delta are involved in insulin-like growth factor I-induced migration of colonic epithelial cells. Gastroenterology (1999) 0.89
Early detection of staurosporine-induced apoptosis by comet and annexin V assays. Histochem Cell Biol (1999) 0.89
Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells. J Biol Chem (1988) 0.88
Urine mutagenicity and lymphocyte DNA damage in fruit growers occupationally exposed to the fungicide captan. Occup Environ Med (2003) 0.88
Individual ribosomal protein pool size and turnover rate in Escherichia coli. J Mol Biol (1974) 0.87
Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy. Ann Oncol (2008) 0.87
DNA damage in mononuclear leukocytes of farmers measured using the alkaline comet assay: discussion of critical parameters and evaluation of seasonal variations in relation to pesticide exposure. Cancer Epidemiol Biomarkers Prev (1998) 0.87
In vitro differentiated HT 29-D4 clonal cell line generates leakproof and electrically active monolayers when cultured in porous-bottom culture dishes. Biol Cell (1989) 0.86
DNA damage in mononuclear leukocytes of farmers measured using the alkaline comet assay: modifications of DNA damage levels after a one-day field spraying period with selected pesticides. Cancer Epidemiol Biomarkers Prev (1998) 0.86
Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening. Br J Cancer (2010) 0.86
Role of endoproteolytic processing in the adhesive and signaling functions of alphavbeta5 integrin. J Biol Chem (2000) 0.86
Acquisition of chemoresistance in a human ovarian carcinoma cell is linked to a defect in cell cycle control. Int J Cancer (1998) 0.85
Characterization of two monoclonal antibodies against the RON tyrosine kinase receptor. Hybridoma (1998) 0.85
Outside-in regulation of integrin clustering processes by ECM components per se and their involvement in actin cytoskeleton organization in a colon adenocarcinoma cell line. Histochem Cell Biol (2000) 0.85
Anticancer and chemosensitizing effects of 2,3-DCPE in ovarian carcinoma cell lines: link with ERK activation and modulation of p21WAF1/CIP1, Bcl-2 and Bcl-xL expression. Gynecol Oncol (2007) 0.85
[Purification of human gastric glycoprotein and a study of its carbohydrate components (author's transl)]. Biochim Biophys Acta (1975) 0.84
The carbohydrate and ester sulfate content of mucosal biopsies in health and in patients with duodenal ulcer. Clin Chim Acta (1974) 0.84
Multi-residue extraction-purification procedure for corticosteroids in biological samples for efficient control of their misuse in livestock production. J Chromatogr B Biomed Sci Appl (2001) 0.84
Measurement of intestinal permeability to mannitol and lactulose as a means of diagnosing food allergy and evaluating therapeutic effectiveness of disodium cromoglycate. Ann Allergy (1987) 0.84
Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cells. J Cell Physiol (1989) 0.84
Biogenesis of alpha6beta4 integrin in a human colonic adenocarcinoma cell line involvement of calnexin. Eur J Biochem (1999) 0.84
Ribavirin-induced resistance to heat shock, inhibition of the Ras-Raf-1 pathway and arrest in G(1). Eur J Pharmacol (2000) 0.83
Activation of cyclic AMP-dependent protein kinases in human gut adenocarcinoma (HT 29) cells in culture. Biochim Biophys Acta (1979) 0.83
Human ovarian adenocarcinoma cells synthesize vitronectin and use It to organize their adhesion. Gynecol Oncol (1999) 0.83
Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4). Eur J Cell Biol (1988) 0.82
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy. Ann Oncol (2010) 0.82
Implication of the alpha v beta 3 integrin in the adhesion of the ovarian-adenocarcinoma cell line IGROV1. Int J Cancer (1995) 0.82
Structural and functional analysis of the human vasoactive intestinal peptide receptor glycosylation. Alteration of receptor function by wheat germ agglutinin. J Biol Chem (1993) 0.82
Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents. Mutagenesis (2005) 0.82
Effect of microtubule disruption on cell adhesion and spreading. Biochem Biophys Res Commun (1998) 0.82
Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose. Eur J Cell Biol (1990) 0.81
Withdrawal time of four pharmaceutical formulations of enrofloxacin in poultry according to different maximum residues limits. J Vet Pharmacol Ther (2010) 0.81
On the control of ribosomal protein biosynthesis in E. coli. III. Studies on a temperature-sensitive mutant defective in the assembly of 30S subunits. Mol Gen Genet (1979) 0.81
HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism. Biochimie (1988) 0.81
Monoclonal antibodies to scorpion toxins. Characterization and molecular mechanisms of neutralization. J Immunol (1988) 0.81
Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29). Eur J Biochem (1985) 0.81
DNA damaging effects of pesticides measured by the single cell gel electrophoresis assay (comet assay) and the chromosomal aberration test, in CHOK1 cells. Mutat Res (1998) 0.81
Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29). Eur J Biochem (1985) 0.81
Type-II insulin-like growth-factor receptor in conditioned medium from HT-29 human colon carcinoma cell line. Int J Cancer (1991) 0.81
Metabolism of tentoxin by hepatic cytochrome P-450 3A isozymes. Eur J Biochem (1997) 0.81
Combination of culture on collagen gels and glucose starvation for cloning human colon cancer cells. Obtention of clones exhibiting different patterns of enterocytic differentiation. Cytotechnology (1991) 0.80
Comet assay and DNA flow cytometry analysis of staurosporine-induced apoptosis. Cytometry (1999) 0.80
Differences in the ribosomal protein gel profile after infection of L cells with wild type or temperature-sensitive mutants of vesicular stomatitis virus. Biochemistry (1977) 0.80
CD4 molecules are restricted to the basolateral membrane domain of in vitro differentiated human colon cancer cells (HT29-D4). FEBS Lett (1990) 0.80
Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29). Eur J Biochem (1986) 0.80